Zhitong Financial App News, Harbin Pharmaceutical Co., Ltd. (600664.SH) issued an announcement. Recently, the company's subsidiary Harbin Pharmaceutical Group Pharmaceutical General Factory (“Harbin Pharmaceutical General Factory”) received the “Drug Supplement Application Approval Notice” for injectable ceftazidime issued by the State Drug Administration. This product passed the consistent evaluation of generic drug quality and efficacy.

Zhitongcaijing · 04/15 08:33
Zhitong Financial App News, Harbin Pharmaceutical Co., Ltd. (600664.SH) issued an announcement. Recently, the company's subsidiary Harbin Pharmaceutical Group Pharmaceutical General Factory (“Harbin Pharmaceutical General Factory”) received the “Drug Supplement Application Approval Notice” for injectable ceftazidime issued by the State Drug Administration. This product passed the consistent evaluation of generic drug quality and efficacy.